Back

Worsening pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia following bevacizumab therapy

31 August 2025 (11:15 - 11:30)
Organised by: Logo
Congress Presentation Part of: Challenges in cardio-oncology (2) Clinical ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Helen Triantafyllidi

Attikon University Hospital, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
Arsenic trioxide-induced non-sustained monomorphic ventricular tachycardia without QT prolongation in acute promyelocytic leukemia
Doctor A. Wasir (Pune, IN)
Slides Video
Presentation thumbnail
A rare case of fulminant talquetamab-induced myocarditis presenting as an acute ST-segment elevation myocardial infarction
Doctor E. Kim (New York City, US)
Slides Video
Presentation thumbnail
A heart under crossfire: the diagnostic challenge of left ventricular dysfunction
Doctor S. Andraz (Faro, PT) Doctor L. Hamann (Faro, PT)
Slides Video

Access the full session

Session thumbnail
Challenges in cardio-oncology (2)
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Session
Unusual cases in pulmonary hypertension
thumbnail
Congress Session
Pulmonary hypertension complexities in investigation and management
thumbnail
Congress Session
Pulmonary hypertension: beyond the pressure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources